Variant report
Variant | esv2762321 |
---|---|
Chromosome Location | chr3:22565896-22574799 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546487158 | chr3:22566614-22566615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs567903083 | chr3:22566642-22566643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs535405222 | chr3:22566650-22566651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs4521248 | chr3:22566691-22566692 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs569746731 | chr3:22566723-22566724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs142921974 | chr3:22566740-22566741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs557796464 | chr3:22566759-22566760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs558886320 | chr3:22566774-22566775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7616475 | chr3:22566823-22566824 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs541476657 | chr3:22566844-22566845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73822632 | chr3:22566896-22566897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559718018 | chr3:22566898-22566899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146593237 | chr3:22566952-22566953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542568697 | chr3:22566956-22566957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563956153 | chr3:22566982-22566983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs532105815 | chr3:22566983-22566984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531201992 | chr3:22567076-22567077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545483864 | chr3:22567173-22567174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564069095 | chr3:22567178-22567179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs141355320 | chr3:22567202-22567203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs546669846 | chr3:22567229-22567230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374956242 | chr3:22567237-22567238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs367683655 | chr3:22567257-22567258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529036080 | chr3:22567258-22567259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs182658267 | chr3:22567261-22567262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552091695 | chr3:22567264-22567265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs74916547 | chr3:22567277-22567278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs1349277 | chr3:22567283-22567284 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs1349278 | chr3:22567301-22567302 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs565840660 | chr3:22567331-22567332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535904081 | chr3:22567353-22567354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570817974 | chr3:22567414-22567415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573131896 | chr3:22567418-22567419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369337571 | chr3:22567432-22567433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542142240 | chr3:22567433-22567434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73822633 | chr3:22567462-22567463 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs553483378 | chr3:22567510-22567511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs575121183 | chr3:22567520-22567521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs369767162 | chr3:22567530-22567531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs188760304 | chr3:22567532-22567533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs192941267 | chr3:22567583-22567584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576017860 | chr3:22567587-22567588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555402343 | chr3:22567589-22567590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs575268342 | chr3:22567651-22567652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs57552258 | chr3:22567692-22567693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs76742806 | chr3:22567694-22567695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs397945200 | chr3:22567695-22567696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572774149 | chr3:22567717-22567718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs140686006 | chr3:22567725-22567726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7629546 | chr3:22567726-22567727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:22566600-22568000 | Enhancers | Fetal Lung | lung |
2 | chr3:22568000-22568400 | Weak transcription | Fetal Lung | lung |
3 | chr3:22568400-22569400 | Enhancers | Fetal Lung | lung |